The Nanomedicine Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Nanomedicine Market is estimated to be USD 125.3 billion in 2017 and predicted to rise to USD 228 billion by 2022 with a CAGR of 12.8%. The market is segmented by Product (Diagnostic Imaging, Regenerative Medicine, Drug Delivery, Implants, Vaccines and Others), by Disease Type (Cardiovascular Diseases, Neurological Diseases, Ophthalmological Diseases, Infectious Diseases, Immunological Diseases, Orthopedic Disorders, Oncological Diseases and Others), by Nanomolecule Type (Nanotubes, Nanoparticles, Nanodevices, Nanoshells and Others). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Increasing applications of nanomaterials such as nanocapsules and nanotubes in drug delivery systems, growing number of cancer and cardiovascular diseases, increasing public and private investments on research activities in nanomedicine and advancements in the biodegradable nanoparticles are the major factors propelling the growth of nanomedicine market. However, unfavorable approval processes possibility for unintended risks during therapies and high cost of treatment using nanomedicine are hindering the market growth.
Based on product, Drug delivery products are accounted for the largest market share. It is due to the incredible precision with which drugs are delivered to the target cells or tissues in the body. Based on type of disease, Oncological diseases segment dominates the market. It is because majority of the research conducted on nanomedicine is focused on developing products for cancer treatment. Cardiovascular diseases segment is expected to be rapidly growing owing to the increase in the geriatric population.
North America leads the Nanomedicine market due to the huge investments on research in nanomedicine from government organizations in Unites States. Asia Pacific is expected to be the fastest growing market due to the high incidences of cancer and cardiovascular diseases owing to large geriatric population.
Some of the major players in Nanomedicine market are Johnson & Johnson, Merck & Co, Pfizer, Abbott Laboratories, GE Healthcare, Celgene Corporation, Nanosphere, Inc, Gilead Sciences, Hoffmann-La Roche, Nanospectra Biosciences, and Arrowhead Pharmaceuticals.
Browse through the full report at “https://www.marketdataforecast.com/market-reports/nanomedicine-market-6468/” and checkout our recent reports in the Diagnosticts at “https://www.marketdataforecast.com/subcategory/diagnostics-5/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.